Zyneyro
Zyneyro is a spin-out from the University of Copenhagen and Marigold Innovation developing next-generation therapies for chronic pain without the typical side effects. Built on 15 years of pioneering neuroscience research, our PICK1-targeting platform addresses the neuronal changes driving chronic pain. Our lead peptide program, ZYN01, aims to deliver rapid, reversible and safer pain relief without the limitations of current treatments.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Zyneyro
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Zyneyro
5 distinct titles indexed · top 5 shown.
- 1chief scientific officer & co-founder
- 1co-founder and part time cdo
- 1research scientist
- 1scientist
- 1senior scientist
Sign up to unlock all 6 contacts at Zyneyro
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Zyneyro
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.